1. Home
  2. WRN vs NPCE Comparison

WRN vs NPCE Comparison

Compare WRN & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRN
  • NPCE
  • Stock Information
  • Founded
  • WRN 2006
  • NPCE 1997
  • Country
  • WRN Canada
  • NPCE United States
  • Employees
  • WRN N/A
  • NPCE N/A
  • Industry
  • WRN Metal Mining
  • NPCE Medical Specialities
  • Sector
  • WRN Basic Materials
  • NPCE Health Care
  • Exchange
  • WRN Nasdaq
  • NPCE Nasdaq
  • Market Cap
  • WRN 435.6M
  • NPCE 363.2M
  • IPO Year
  • WRN N/A
  • NPCE 2021
  • Fundamental
  • Price
  • WRN $2.08
  • NPCE $10.62
  • Analyst Decision
  • WRN Strong Buy
  • NPCE Strong Buy
  • Analyst Count
  • WRN 2
  • NPCE 6
  • Target Price
  • WRN $4.13
  • NPCE $16.67
  • AVG Volume (30 Days)
  • WRN 1.5M
  • NPCE 116.7K
  • Earning Date
  • WRN 11-05-2025
  • NPCE 11-04-2025
  • Dividend Yield
  • WRN N/A
  • NPCE N/A
  • EPS Growth
  • WRN N/A
  • NPCE N/A
  • EPS
  • WRN N/A
  • NPCE N/A
  • Revenue
  • WRN N/A
  • NPCE $88,570,000.00
  • Revenue This Year
  • WRN N/A
  • NPCE $22.13
  • Revenue Next Year
  • WRN N/A
  • NPCE $6.07
  • P/E Ratio
  • WRN N/A
  • NPCE N/A
  • Revenue Growth
  • WRN N/A
  • NPCE 23.32
  • 52 Week Low
  • WRN $0.90
  • NPCE $6.03
  • 52 Week High
  • WRN $2.56
  • NPCE $18.98
  • Technical
  • Relative Strength Index (RSI)
  • WRN 51.43
  • NPCE 53.23
  • Support Level
  • WRN $2.00
  • NPCE $10.42
  • Resistance Level
  • WRN $2.19
  • NPCE $11.14
  • Average True Range (ATR)
  • WRN 0.15
  • NPCE 0.48
  • MACD
  • WRN -0.05
  • NPCE -0.06
  • Stochastic Oscillator
  • WRN 15.79
  • NPCE 42.97

About WRN Western Copper and Gold Corporation

Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: